Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV817
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a ceiling value of $14,592.57 and an ultimate completion date of February 19, 2026. This delivery order was competitively awarded with no set-aside designation and represents a task order executed under AmerisourceBergen's parent company, Cencora, Inc.'s, substantially larger Indefinite Delivery Contract with DLA Troop Support Medical. That IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supply products to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this order—is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The company's demonstrated capability to fulfill competitive federal contracts across diverse therapeutic domains, combined with its strategic role as a pharmaceutical prime vendor for DLA, positions it to efficiently deliver essential medications such as Vyndamax to support military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FV817?
SPE2DR26FV817 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV817 worth?
The government has obligated $14,593 on SPE2DR26FV817.
Is contract SPE2DR26FV817 an order under another contract?
Yes. SPE2DR26FV817 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV817 competed?
The extent of competition for SPE2DR26FV817 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award